Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda

NCT00599326 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Porphyria Cutanea Tarda

Interventions

DRUG: Deferasirox

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]